Article
The chordoid glioma PRKCA D463H mutation is a kinase inactive, gain-of-function allele that induces early-onset chondrosarcoma in mice.
Science signaling - 4 Nov 2025
Calleja Véronique, Henry Jack C, Cobbaut Mathias, Sewell Joanne, Rizzoti Karine, Houghton Francesca, Boeing Stefan, Anyanwu Nneka, Varsani-Brown Sunita, Snoeks Thomas, Suárez-Bonnet Alejandro, Priestnall Simon L, McDonald Neil Q, Cameron Angus J M, Parker Peter J
Abstract excerpt
The penetrant D463H mutation in PRKCA, which encodes the kinase PKCα, is a biomarker and driver of chordoid glioma, a type of brain cancer. Here, we found that heterozygous knock-in expression of the D463H mutant in mice elicited the development of chondrosarcomas. The mutant protein kinase was catalytically inactive, but no such oncogenic phenotype was observed for the related inactivating mutation D463N,...
Read the complete abstract on PubMedTopics
- Animals
- Protein Kinase C-alpha
- Mice
- Chondrosarcoma
- Gain of Function Mutation
